ArticleBlood advances2025

ATM inhibition decreases ERK activation and is synergistic with ibrutinib in primary chronic lymphocytic leukemia cells.

Sara E F Kost et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.